Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 126 participants.
Also called NCT07073768
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 126 participants
- Sponsor
- Khyber Medical College, Peshawar
- Registry
-
NCT07073768
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT07073768. Randomized; no masking; primary purpose treatment. Start 2025-07-01 (actual); primary completion 2026-12-26 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
- Condition
- Diabetes Mellitus Type 2
- Condition
- Glycemic Control for Diabetes Mellitus
- Intervention (Drug)
- Trelagliptin 100 mg
- Intervention (Drug)
- Sitagliptin 100mg OD
- Lead sponsor
- Khyber Medical College, Peshawar
Record details
- Record id
cardio:ct-nct07073768- Content hash
d20e4ad1e8e3c08c8a3ad72db43f8b5d54ba52af85d3984fe18c408b4f4882ab